These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2416619)

  • 1. Abnormalities of insulin responses after ambient and previous exposure to glucose in streptozocin-diabetic and dexamethasone-treated rats. Role of hyperglycemia and increased B-cell demands.
    Grill V; Rundfeldt M
    Diabetes; 1986 Jan; 35(1):44-51. PubMed ID: 2416619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell insensitivity in a rat model of non-insulin-dependent diabetes. Evidence for a rapidly reversible effect of previous hyperglycemia.
    Grill V; Westberg M; Ostenson CG
    J Clin Invest; 1987 Sep; 80(3):664-9. PubMed ID: 2442195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutrient-induced priming of insulin and glucagon secretion. Effects of alpha-ketoisocaproic acid.
    Grill V
    Endocrinology; 1982 Mar; 110(3):1013-7. PubMed ID: 6173206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal insulin secretion in a streptozocin model of diabetes. Effects of insulin treatment.
    Leahy JL; Bonner-Weir S; Weir GC
    Diabetes; 1985 Jul; 34(7):660-6. PubMed ID: 2408948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal D cell secretion in alloxan-diabetes: influence by drug and aberrant metabolism.
    Grill V; Efendić S
    Am J Physiol; 1984 Jun; 246(6 Pt 1):E483-92. PubMed ID: 6204535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation.
    Sako Y; Grill VE
    Endocrinology; 1990 Oct; 127(4):1580-9. PubMed ID: 1698143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple abnormalities in insulin responses to nonglucose nutrients in neonatally streptozotocin diabetic rats.
    Grill V; Sako Y; Ostenson CG; Jalkanen P
    Endocrinology; 1991 Apr; 128(4):2195-203. PubMed ID: 1706269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal B-cell function in neonatally streptozotocin-diabetic rats: insensitivity to alloxan toxicity.
    Grill V; Westberg M
    Endocrinology; 1987 Dec; 121(6):2171-6. PubMed ID: 2445559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal regulation by glucose of somatostatin secretion in the perfused pancreas of NIDDM rats.
    Ostenson CG; Efendic S; Grill V
    Pancreas; 1990 May; 5(3):347-53. PubMed ID: 1971441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose insensitivity and amino-acid hypersensitivity of insulin release in rats with non-insulin-dependent diabetes. A study with the perfused pancreas.
    Giroix MH; Portha B; Kergoat M; Bailbe D; Picon L
    Diabetes; 1983 May; 32(5):445-51. PubMed ID: 6341128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
    Portha B; Serradas P
    Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diazoxide infusion at excess but not at basal hyperglycemia enhances beta-cell sensitivity to glucose in vitro in neonatally streptozotocin-diabetic rats.
    Sako Y; Grill VE
    Metabolism; 1992 Jul; 41(7):738-43. PubMed ID: 1535679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
    Serradas P; Bailbé D; Portha B
    Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preserved initiatory and potentiatory effect of alpha-ketoisocaproate on insulin release in islets of glucose intolerant rats.
    Guenifi A; Abdel-Halim SM; Efendic S; Ostenson CG
    Diabetologia; 1998 Nov; 41(11):1368-73. PubMed ID: 9833946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased beta-cell secretory responsiveness to ceruletide and TPA in streptozocin-induced mildly diabetic rats.
    Okabayashi Y; Otsuki M; Ohki A; Tani S; Baba S
    Diabetes; 1989 Aug; 38(8):1042-7. PubMed ID: 2526762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired insulin biosynthetic capacity in a rat model for non-insulin-dependent diabetes. Studies with dexamethasone.
    Giddings SJ; Orland MJ; Weir GC; Bonner-Weir S; Permutt MA
    Diabetes; 1985 Mar; 34(3):235-40. PubMed ID: 3882490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass.
    Leahy JL; Bonner-Weir S; Weir GC
    Diabetes; 1984 Jul; 33(7):667-73. PubMed ID: 6203798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats.
    Pederson RA; Ramanadham S; Buchan AM; McNeill JH
    Diabetes; 1989 Nov; 38(11):1390-5. PubMed ID: 2695373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of glucose-induced insulin secretion in a rat model of NIDDM is not accompanied by return of the B-cell GLUT2 glucose transporter.
    Chen C; Thorens B; Bonner-Weir S; Weir GC; Leahy JL
    Diabetes; 1992 Oct; 41(10):1320-7. PubMed ID: 1397706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducement by fat feeding of basal hyperglycemia in rats with abnormal beta-cell function. Model for study of etiology and pathogenesis of NIDDM.
    Pascoe WS; Storlien LH
    Diabetes; 1990 Feb; 39(2):226-33. PubMed ID: 2146180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.